About this item:

379 Views | 445 Downloads

Author Notes:

Address correspondence to Marielle Cavrois, mcavrois@gladstone.ucsf.edu

We thank G. Lewis for the gift of the b13 antibody, S. Allen and J. Mulenda for establishing the Lusaka cohort, K. Eilertson of the Gladstone Bioinformatic Core, and M. Gesner of the Gladstone Flow Core for their contributions; G. Howard and A. Lucido for editorial assistance; T. Roberts for graphic arts; and S. Cammack and R. Givens for administrative assistance.

Thanks go to W. Yonemoto, B. Webster, and the members of the Women's HIV-1 Program for discussions.

We also thank the staff, interns, and subjects enrolled in the Lusaka cohort and the healthy blood donors.

Subjects:

Research Funding:

This study was supported by funding from the National Institutes of Health (P01 AI083050). UCSF-GIVI CFAR provided infrastructure support (P30 AI27763;).

These studies were also made possible by grant RR 18928-01 from the NIH National Center for Research Resources.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Virology
  • VIROLOGY
  • IMMUNODEFICIENCY-VIRUS TYPE-1
  • NEUTRALIZING ANTIBODY-RESPONSES
  • DISEASE PROGRESSION
  • HETEROSEXUAL TRANSMISSION
  • GLYCOSYLATION SITES
  • VARIABLE REGIONS
  • DENDRITIC CELLS
  • MEMBRANE-FUSION
  • 6-HELIX BUNDLE
  • V2 REGIONS

Enhanced Fusion and Virion Incorporation for HIV-1 Subtype C Envelope Glycoproteins with Compact V1/V2 Domains

Tools:

Journal Title:

Journal of Virology

Volume:

Volume 88, Number 4

Publisher:

, Pages 2083-2094

Type of Work:

Article | Final Publisher PDF

Abstract:

In infected people, the HIV-1 envelope glycoprotein (Env) constantly evolves to escape the immune response while retaining the essential elements needed to mediate viral entry into target cells. The extensive genetic variation of Env is particularly striking in the V1/V2 hypervariable domains. In this study, we investigated the trade-off, in terms of fusion efficiency, for encoding V1/V2 domains of different lengths. We found that natural variations in V1/V2 length exert a profound impact on HIV-1 entry. Variants encoding compact V1/V2 domains mediated fusion with higher efficiencies than related Envs encoding longer V1/V2 domains. By exchanging the V1/V2 domains between Envs of the same infected person or between two persons linked by a transmission event, we further demonstrated that V1/V2 domains critically influence both Env incorporation into viral particles and fusion to primary CD4 T cells and monocyte-derived dendritic cells. Shortening the V1/V2 domains consistently increased Env incorporation and fusion, whereas lengthening the V1/V2 domains decreased Env incorporation and fusion. Given that in a new host transmitted founder viruses are distinguished by compact Envs with fewer glycosylation sites, our study points to fusion and possibly Env incorporation into virions as limiting steps for transmission of HIV-1 to a new host and suggests that the length and/or the N-glycosylation profile of the V1/V2 domain influences these early steps in the HIV life cycle.

Copyright information:

© 2014, American Society for Microbiology.

Export to EndNote